Preoperative anemia in elective cardiac surgery: Prevalence, risk factors, and influence on postoperative outcome

Transfusion Alternatives in Transfusion Medicine

Volumn 11, Issue 2, 2010, Pages 47-56

  Muñoz, Manuel ^a   Ariza, Daniel ^b   Gómez Ramírez, Susana ^b   Hernández, Paula ^b   García Erce, José A ^c   Leal Noval, Santiago R ^d  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Allogeneic blood transfusion; Cardiac surgery; Postoperative outcome; Preoperative anemia

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; NITRITE; PROTAMINE SULFATE; PROTON PUMP INHIBITOR;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHRONIC KIDNEY DISEASE; DEATH; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEART VALVE REPLACEMENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE ANEMIA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STROKE;

EID: 77954103532     PISSN: 12959022     EISSN: 1778428X     Source Type: Journal    
DOI: 10.1111/j.1778-428X.2010.01126.x     Document Type: Article

References (50)

1. Leal-Noval SR, Rincón-Ferrari MD, García-Curiel A. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001, 119:1461-8.
2. Leal-Noval SR, Jara-López I, García-Garmendia JL. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003, 98:815-22.
3. Banbury MK, Brizzio ME, Rajeswaran J, Lytle BW, Blackstone EH. Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg 2006, 202:131-8.
4. Engoren MC, Habib RH, Zachrarias A. Effect of blood transfusion on long-term survival after cardiac surgery. Ann Thorac Surg 2002, 74:1180-6.
5. Juffé Stein A. [Coronary bypass surgery in the elderly]. Rev Esp Cardiol 2001, 54:677-8.
6. Garcia Fuster R, Montero JA, Gil O. Trends in coronary artery bypass surgery: changing type of surgical patients. Rev Esp Cardiol 2005, 58:27-32.
7. Karkouti K, Cohen MM, McCluskey SA, Sher GD. A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass graft surgery. Transfusion 2001, 41:1193-203.
8. Ferraris VA, Ferraris SP, Singh A. Operative outcome and hospital cost. J Thorac Cardiovasc Surg 1998, 115:593-602. discussion 602-3
9. Khanna MP, Hebert PC, Fergusson DA. Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. Transfus Med Rev 2003, 17:110-19.
10. Parr KG, Patel MA, Dekker R. Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth 2003, 17:176-81.
11. DeFoe GR, Ross CS, Olmstead EM. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northen England Cardiovascular Disease Study Group. Ann Thorac Surg 2001, 71:769-76.
12. Zindrou D, Taylor KM, Bigger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002, 359:1747-8.
13. Koch CG, Weng Y, Zhou SX. Prevalence of risk factors, and not gender per se, determines short- and long-term survival alter coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2003, 17:585-93.
14. Kulier A, Levin J, Moser R. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007, 116:471-9.
15. Karkouti K, Wijeysundera DN, Beattie WS. Reducing Bleeding in Cardicac Surgery (RBC) Investigators. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008, 117:478-84.
16. Muñoz M, García-Erce JA, Leal-Noval SR. Perioperative transfusion in anaemic patients undergoing coronary artery bypass. Lancet 2002, 360:1427-8.
17. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007, 83:S27-S86. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, Suppl
18. Cladellas M, Bruguera J, Comin J. Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement? Eur Heart J 2006, 27:1093-9.
19. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. Centres for Disease Control definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992, 13:606-8.
20. Grossman RF, Fein A. Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia. Chest 2000, 117(2):177S-81S. Suppl
21. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996, 61:1030-6.
22. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991, 115:457-69.
23. Gaskell H, Derry S, Moore RA, McQuay HJ. Prevalence of anaemia in older persons: systematic review. BMC Geriatr 2008, 8:1. doi:10.1186/1471-2318-8-1
24. Caramelo C, Just S, Gil P. Anemia in heart failure: pathophysiology, pathogenesis, treatment, and incognitae]. Rev Esp Cardiol 2007, 60:848-60.
25. Maxwell AP, Ong HY, Nicholls D. Influence of progressive renal dysfunction in chronic heart failure. Eur J Heart Fail 2002, 4:125-30.
26. Androne AS, Katz SD, Lund L. Hemodilution is common in patients with advanced heart failure. Circulation 2003, 35:1737-44.
27. Adlbrecht C, Kommata S, Hülsmann M. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume. Eur Heart J 2008, 29:2343-50.
28. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. The prevalence of anemia in persons aged 65 and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004, 104:2263-8.
29. Karski JM, Mathieu M, Cheng D, Carroll J, Scott GJ. Etiology of preoperative anemia in patients undergoing scheduled cardiac surgery. Can J Anaesth 1999, 46:979-82.
30. Aymard JP, Aymard B, Netter P. Haematological adverse effects of histamine H2-receptor antagonists. Med Toxicol Adverse Drug Exp 1988, 3:430-48.
31. Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J 2004, 97:887-9.
32. Howden CW. Vitamin B12 levels during prolonged treatment with proton pump inhibitors. J Clin Gastroenterol 2000, 30:29-33.
33. Andrès E, Noel E, Ben Abdelghani M. Vitamin B12 deficiency associated with chronic acid suppression therapy. Ann Pharmacother 2003, 37:1730.
34. Muñoz M, Leal-Noval R, García-Erce JA. Intravenous iron in cardiac surgery. Semin Hematol 2006, 43(6):S39-S42. Suppl
35. Muñoz M, Breymann C, García-Erce JA. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008, 94:172-83.
36. Ishani A, Weinhandl E, Zhao Z. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2005, 3:391-9.
37. Rapamonti V, Racca V, Calvo MA, Castiglioni P, Ferratini M. Angiotensin-converting enzyme inhibitors slow recovery from anemia following cardiac surgery. Chest 2006, 130:79-84.
38. Macdougall IC. ACE inhibitors and erythropoietin responsiveness. Am J Kidney Dis 2001, 38:649-51.
39. Litmathe J, Boeken U, Feindt P, Gams E. Predictors of homologous blood transfusion for patients undergoing open heart surgery. Thorac Cardiovasc Surg 2003, 51:17-21.
40. Karkouti K, Wijeysundera DN, Yau TM. The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. Transfusion 2008, 48:666-72.
41. Surgenor SD, DeFoe GR, Fillinger MP. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 2006, 114(1):I143-8. Suppl
42. Wu WC, Schifftner TL, Henderson WG. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007, 13:2481-8.
43. Ribera A, Ferreira-González I, Cascant P, Pons JMV, Permanyer-Miralda G. ARCA study group. [Evaluation of risk-adjusted hospital mortality after coronary artery bypass graft surgery in the Catalan public healthcare system. Influence of hospital management type (ARCA Study)]. Rev Esp Cardiol 2006, 59:431-40.
44. Surgenor SD, Kramer RS, Olmstead EM. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009, 108:1741-6.
45. Vamvakas EC. White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis. Vox Sang 2007, 92:224-32.
46. Koch CG, Li L, Sessler DI. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008, 358:1229-39.
47. Fleiss JL. Determining sample sizes needed to detect a difference between two proportions. Statistical Methods for Rates and Proportions 1981, 38-45. Fleiss JLLewin BChopaile M. eds, 2nd, edn., Wiley, New York, pp.
48. Madi-Jebara S, Sleilaty GS, Achouh PE. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin in not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 2004, 18:59-63.
49. Karkouti K, McCluskey SA, Ghannam M. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006, 53:11-19.
50. Beris P, Muñoz M, García-Erce JA. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008, 100:599-604.